Chromos, Targeted Genetics deal

CHR completed the acquisition of TGEN subsidiary CellExSys Inc. (Seattle, Wash.) for about C$4.5 million (US$3.4 million) (see BioCentury, June 28). TGEN owned about 80% of CellExSys. The other share...